Mylan and Mapi Pharma announced today that the two companies will partner on the development and commercialization of GA Depot, a long-acting Glatiramer Acetate product. Mylan is acquiring global... read more
Mylan and Mapi Pharma announced today that the two companies will partner on the development and commercialization of GA Depot, a long-acting Glatiramer Acetate product. Mylan is acquiring global... read more
Inflammatix announced today that it has been named a finalist in Fast Company's 2018 World Changing Ideas Awards for its novel HostDx tests, which read the immune system to tackle the global... read more
AbbVie and Neurocrine announced notification by the U.S. Food and Drug Administration (FDA) that it requires extended time to review additional information regarding the results of liver... read more
vTv (Nasdaq:VTVT) today announced that results from Part A of the Company’s Phase 3 STEADFAST study of the investigational medication azeliragon in people with mild Alzheimer’s disease did not... read more
Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report further data analysis from its successfully completed Phase 2 clinical... read more